BE874430A - 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique - Google Patents

2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique

Info

Publication number
BE874430A
BE874430A BE1/9287A BE1009287A BE874430A BE 874430 A BE874430 A BE 874430A BE 1/9287 A BE1/9287 A BE 1/9287A BE 1009287 A BE1009287 A BE 1009287A BE 874430 A BE874430 A BE 874430A
Authority
BE
Belgium
Prior art keywords
dihydroimidazo
therapeutic use
substituted pyrimidines
pyrimidines
substituted
Prior art date
Application number
BE1/9287A
Other languages
English (en)
Inventor
W W Turner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE874430A publication Critical patent/BE874430A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE1/9287A 1978-03-09 1979-02-26 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique BE874430A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/884,884 US4153695A (en) 1978-03-09 1978-03-09 Substituted 2,3-dihydro imidazo[1,2-c]pyrimidines

Publications (1)

Publication Number Publication Date
BE874430A true BE874430A (fr) 1979-08-27

Family

ID=25385633

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9287A BE874430A (fr) 1978-03-09 1979-02-26 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique

Country Status (14)

Country Link
US (1) US4153695A (fr)
EP (1) EP0004173B1 (fr)
JP (1) JPS54145697A (fr)
BE (1) BE874430A (fr)
CA (1) CA1105014A (fr)
CH (1) CH639092A5 (fr)
DE (1) DE2963706D1 (fr)
DK (1) DK96379A (fr)
FR (1) FR2419291A1 (fr)
GB (1) GB2016009B (fr)
HU (1) HU177992B (fr)
IE (1) IE48389B1 (fr)
IL (1) IL56746A (fr)
LU (1) LU81002A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4408047A (en) * 1980-03-28 1983-10-04 Merck & Co., Inc. Imidazodiazines
US4374988A (en) * 1981-11-05 1983-02-22 American Cyanamid Company 4-Heteroarylimidazo-[1,5-A]pyrimidines
US4503050A (en) * 1983-06-02 1985-03-05 Riker Laboratories, Inc. Substituted imidazo[1,2-c]pyrimidines
US4473570A (en) * 1983-08-02 1984-09-25 Riker Laboratories, Inc. Imidazo[1,5-c]pyrimidin-5-ones
US4478835A (en) * 1983-08-02 1984-10-23 Riker Laboratories, Inc. Substituted imidazo[1,5-c]pyrimidines
DE3638121A1 (de) * 1986-05-30 1987-12-03 Bayer Ag 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2118261A1 (de) * 1971-04-15 1972-11-02 C.H. Boehringer Sohn, 6507 Ingelheim Neue N-haltige Bicyclen, deren Säureadditionssalze sowie Verfahren zu deren Herstellung
JPS523957B2 (fr) * 1974-03-14 1977-01-31

Also Published As

Publication number Publication date
IL56746A (en) 1982-08-31
CA1105014A (fr) 1981-07-14
GB2016009A (en) 1979-09-19
DK96379A (da) 1979-09-10
IE790579L (en) 1979-09-09
CH639092A5 (fr) 1983-10-31
JPS54145697A (en) 1979-11-14
IL56746A0 (en) 1979-05-31
IE48389B1 (en) 1985-01-09
DE2963706D1 (en) 1982-11-04
EP0004173B1 (fr) 1982-09-22
LU81002A1 (fr) 1979-06-18
FR2419291A1 (fr) 1979-10-05
FR2419291B1 (fr) 1980-11-14
GB2016009B (en) 1982-08-11
EP0004173A1 (fr) 1979-09-19
HU177992B (en) 1982-02-28
US4153695A (en) 1979-05-08

Similar Documents

Publication Publication Date Title
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE877394A (fr) Phenethanolamines et leur utilisation therapeutique
BE879586A (fr) Phosphinylalcanoyl prolines, leur preparation et leur utilisation
FR2504931B1 (fr) Ionomeres modifies, leur preparation et leur utilisation
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
FR2439197B1 (fr) 1-thia-3-aza-4-ones, substituees, leur preparation et leur utilisation en agriculture
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
BE877263A (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
BE877390A (fr) R-n-(2-phenyl-2-hydroxyethyl)-3-phenylpropylamines et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE874662A (fr) Benzocycloheptapyrannes et leur utilisation therapeutique
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique
BE880288A (fr) Hexahydro-2,6-methano-3-benzazocines, leur preparation et leur utilisation therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ELI LILLY AND CY

Effective date: 19850226